Heart Failure

>

The HCPLive heart failure page is a resource for medical news and expert insights on HF. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for heart disease, reduced and preserved ejection fraction, and more.

Latest News

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
FDA Approves Acoramidis (Attruby) for ATTR-CM

November 23rd 2024

With approval, acoramaidis becomes the first agent with a label specifying near-complete stabilization of TTR.

Bumetanide Nasal Spray Equivalent to Oral, IV Forms for Heart Failure| Image Credit: American Heart Association
Bumetanide Nasal Spray Equivalent to Oral, IV Forms for Heart Failure

November 18th 2024

Sacubtril/Valsartan Lowers Risk of Cardiotoxicity Linked to Chemotherapy | Image Credit: American Heart Association
Sacubtril/Valsartan Lowers Cardiotoxicity Risk Linked to Chemotherapy

November 18th 2024

VANISH2: Catheter Ablation Viable First-Line Option for Ventricular Tachycardia | Image Credit: American Heart Association
VANISH2: Catheter Ablation Viable First-Line Option for Ventricular Tachycardia

November 16th 2024

Milton Packer, MD | Credit: American Heart Association
SUMMIT Trial Proves Tirzepatide's Benefit in HFpEF with Obesity

November 16th 2024

<1
...
4445464748
© 2024 MJH Life Sciences

All rights reserved.